Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria.

Author information

Affiliations

  • 1. Institute for Genetics, Centre for Molecular Medicine, University of Cologne, 50674 Cologne, Germany.
      Authors
    • Merkwirth C 1
    (1 author)

ORCIDs linked to this article

Genes & Development, 01 Feb 2008, 22(4):476-488
https://doi.org/10.1101/gad.460708 PMID: 18281461 PMCID: PMC2238669

Free full text in Europe PMC

A comment on this article appears in "Mitophagy: Permitted by Prohibitin." Curr Biol. 2017 Jan 23;27(2):R73-R76.

Abstract 

Prohibitins comprise an evolutionarily conserved and ubiquitously expressed family of membrane proteins with poorly described functions. Large assemblies of PHB1 and PHB2 subunits are localized in the inner membrane of mitochondria, but various roles in other cellular compartments have also been proposed for both proteins. Here, we used conditional gene targeting of murine Phb2 to define cellular activities of prohibitins. Our experiments restrict the function of prohibitins to mitochondria and identify the processing of the dynamin-like GTPase OPA1, an essential component of the mitochondrial fusion machinery, as the central cellular process controlled by prohibitins. Deletion of Phb2 leads to the selective loss of long isoforms of OPA1. This results in an aberrant cristae morphogenesis and an impaired cellular proliferation and resistance toward apoptosis. Expression of a long OPA1 isoform in PHB2-deficient cells suppresses these defects, identifying impaired OPA1 processing as the primary cellular defect in the absence of prohibitins. Our results therefore assign an essential function for the formation of mitochondrial cristae to prohibitins and suggest a coupling of cell proliferation to mitochondrial morphogenesis.

Free full text 

Logo of genesdevCSHL PressJournal HomeSubscriptionseTOC AlertsBioSupplyNetGenes & Development
Genes Dev. 2008 Feb 15; 22(4): 476–488.
PMCID: PMC2238669
PMID: 18281461

Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria

Carsten Merkwirth,1 Sascha Dargazanli,1 Takashi Tatsuta,1 Stefan Geimer,2 Beatrix Löwer,2 F. Thomas Wunderlich,1 Jürgen-Christoph von Kleist-Retzow,3 Ari Waisman,1,4 Benedikt Westermann,2 and Thomas Langer1,5
Author information Article notes Copyright and License information Disclaimer

Abstract

Prohibitins comprise an evolutionarily conserved and ubiquitously expressed family of membrane proteins with poorly described functions. Large assemblies of PHB1 and PHB2 subunits are localized in the inner membrane of mitochondria, but various roles in other cellular compartments have also been proposed for both proteins. Here, we used conditional gene targeting of murine Phb2 to define cellular activities of prohibitins. Our experiments restrict the function of prohibitins to mitochondria and identify the processing of the dynamin-like GTPase OPA1, an essential component of the mitochondrial fusion machinery, as the central cellular process controlled by prohibitins. Deletion of Phb2 leads to the selective loss of long isoforms of OPA1. This results in an aberrant cristae morphogenesis and an impaired cellular proliferation and resistance toward apoptosis. Expression of a long OPA1 isoform in PHB2-deficient cells suppresses these defects, identifying impaired OPA1 processing as the primary cellular defect in the absence of prohibitins. Our results therefore assign an essential function for the formation of mitochondrial cristae to prohibitins and suggest a coupling of cell proliferation to mitochondrial morphogenesis.

[Keywords: Prohibitin, OPA1, mitochondrial fusion, mitochondrial cristae, apoptosis]

Mitochondria are multifunctional, reticulated organelles intimately embedded in cellular physiology (Chan 2006a; McBride et al. 2006). Dynamic morphological alterations of mitochondria allow the adaptation of their activities to cellular demands in time and space (Okamoto and Shaw 2005; Chan 2006b; Hoppins et al. 2007). At least four dynamin-related GTPases mediate the fission and fusion of mitochondrial membranes and determine the shape of the mitochondrial reticulum: mitofusins (MFN1 and MFN2) in the outer and OPA1 in the inner membrane control mitochondrial membrane fusion, while DRP1 triggers fission events. Mutations in MFN2 and OPA1 cause neurodegeneration (Alexander et al. 2000; Delettre et al. 2000; Züchner et al. 2004), illustrating the importance of mitochondrial dynamics for neuronal functions.

Prohibitins comprise an evolutionarily conserved family of membrane proteins whose function is poorly understood (Nijtmans et al. 2002; Mishra et al. 2005). Multiple copies of two homologous subunits, PHB1 (BAP32, often simply termed prohibitin) and PHB2 (BAP37, REA), form large complexes in the inner membrane of mitochondria (Ikonen et al. 1995; Coates et al. 1997; Berger and Yaffe 1998). The ring-like shape of yeast prohibitin complexes (Back et al. 2002; Tatsuta et al. 2005) and the sequence similarity to lipid raft-associated proteins of the SPFH family suggest a scaffolding function of prohibitins, which may define membrane microdomains (Tavernarakis et al. 1999; Langhorst et al. 2005; Morrow and Parton 2005; Browman et al. 2007). Such an activity could explain synthetic lethal interactions of prohibitins with a diverse set of genes in yeast (Berger and Yaffe 1998; Birner et al. 2003; Nolden et al. 2005; Osman et al. 2007) as well as multiple cellular roles that have been assigned to prohibitins in mammals.

Inactivation of prohibitin genes in multicellular organisms like mouse and Caenorhabditis elegans revealed essential functions during organismal development (Sanz et al. 2003; Park et al. 2005). However, the molecular basis of these loss-of-function phenotypes is unclear. Most importantly, although a mitochondrial localization is widely accepted, PHB1 and PHB2 have also been identified in the nucleus and the plasma membrane in certain mammalian cell lines (Fusaro et al. 2003; Kurtev et al. 2004; Kasashima et al. 2006). Subunits of prohibitins have been suggested to regulate cell cycle and apoptotic processes by interacting with retinoblastoma tumor suppressor protein and p53 (Nuell et al. 1991; Wang et al. 2002; Kasashima et al. 2006), to repress the transcriptional activity of estrogen receptors by interacting with histone deacetylases (Montano et al. 1999; Kurtev et al. 2004), to modulate epithelial cell adhesion and migration by interacting with c-Raf (Rajalingam et al. 2005), or to function as cell surface receptors (Terashima et al. 1994; Mengwasser et al. 2004; Sharma and Quadri 2004). It should be noted, however, that many of these studies did not consider a mitochondrial localization of prohibitins and addressed only the function of either PHB1 or PHB2, although both proteins have been demonstrated to assemble quantitatively with each other (Coates et al. 2001).

Here, we used conditional gene targeting of murine Phb2 and define an essential role of the prohibitin complex for the processing of OPA1 within mitochondria that results in impaired cell proliferation, resistance toward apoptosis, and mitochondrial cristae morphogenesis.

Results

Conditional gene targeting of murine Phb2

To investigate the function of PHB2 in vivo, we used conditional gene targeting using Cre-loxP-mediated recombination. The murine Phb2 gene is located on Chromosome 6 and composed of nine exons (Fig. 1A). We constructed a gene replacement vector that introduced a gene cassette consisting of the neomycin resistance gene (Neo) and a flanking loxP site upstream of exon 3 and a loxP site downstream from exon 4 into the endogenous Phb2 gene (Fig. 1A). Deletion of the loxP-flanked exons 3 and 4 by Cre-recombinase causes a frameshift mutation resulting in a stop of translation at amino acid 73 of PHB2. After injection of embryonic stem (ES) cells harboring the targeted allele (Supplemental Fig. S1) germline transmission was confirmed by Southern blot analysis (Fig. 1B). Heterozygous Phb2+/− animals were generated upon breeding of Phb2fl/+ mice with a Cre-transgenic mouse strain allowing universal expression of Cre-recombinase in all tissues (Schwenk et al. 1995). Intercrossings of Phb2+/− mice neither revealed viable Phb2−/− offspring nor were homozygous mutant embryos identified before embryonic day 8.5 (Supplemental Table S1). Similarly, breeding of Phb2fl/+ mice with a Cre line expressing Cre-recombinase specifically in the brain did not produce viable offspring (Supplemental Table S1). These findings are in agreement with previous observations using a conventional knockout strategy (Park et al. 2005) and suggest an essential function of PHB2 in early embryonic development.

An external file that holds a picture, illustration, etc. Object name is 476fig1.jpg

Conditional inactivation of murine Phb2 in vivo and in vitro. (A) Schematic representation of the wild-type Phb2 locus (WT), the targeting vector (TV), the targeted Phb2fl(neo)/+ locus after homologous recombination (FN), the conditional Phb2fl/fl locus after Flpe-mediated recombination (F), and the knockout locus upon Cre-mediated recombination (Δ). Positive and negative selection markers (NeoR and TK), exons (black bars), FRT and loxP sites (black ovals and black triangles, respectively), external probes (black boxes, A and B), locations of PCR primers (black arrows, P1–P3), and relevant HindIII restriction sites (H) are indicated. (B) Southern blot analysis of germline transmitted offspring harboring the targeted Phb2fl(neo)/+ locus. Genomic DNA isolated from ES cells and tail biopsies was digested with HindIII, hybridized, and analyzed by autoradiography. (C) PCR analysis of DNA isolated from MEFs. Amplified DNA fragments for the wild-type (WT), floxed (flox), and knockout (Δ) locus are shown. (D) Immunoblot analysis of total protein lysates. MEFs, transduced with Cre-recombinase when indicated, were lysed and analyzed by immunoblotting using PHB1- and PHB2-specific antibodies. A cross-reacting band was used as a loading control. (E) RT–PCR analysis of Phb1 and Phb2 transcripts in Phb2-deficient and control MEFs. Transcripts of β-actin were used as control.

To define functional consequences of a deletion of Phb2, mouse embryonic fibroblasts (MEFs) were isolated from homozygous Phb2fl/fl embryos and transduced with purified Cre-recombinase, leading to efficient deletion of Phb2 in vitro (Fig. 1C). Western blot analysis confirmed the absence of PHB2 in Phb2−/− cells (Fig. 1D). Notably, depletion of PHB2 was accompanied by the loss of its assembly partner PHB1 (Fig. 1D). RT–PCR experiments demonstrated that transcription of Phb1 proceeds irrespective of the presence of Phb2 in the cells (Fig. 1E). Thus, similar to other organisms (Berger and Yaffe 1998; Sanz et al. 2003), murine PHB1 and PHB2 are functionally interdependent, defining the assembled prohibitin complex as the functionally active unit.

PHB2 ensures cell proliferation and protects against apoptosis

The effect of Phb2 deletion on cell proliferation was assessed by determining the 3H-thymidine incorporation in Phb2fl/+ and Phb2fl/fl fibroblasts transduced with Cre-recombinase. Whereas Cre-transduction did not affect DNA labeling in heterozygous Phb2fl/+ cells, incorporation of 3H-thymidine was strongly impaired in cells lacking PHB2 (Fig. 2A). Consistently, cell growth was impaired in Phb2fl/fl cells after Cre-transduction (Phb2−/−) (Fig. 2B).

An external file that holds a picture, illustration, etc. Object name is 476fig2.jpg

Phb2 is required for cell proliferation and apoptotic resistance. (A) Incorporation of 3H-thymidine in MEFs after Cre-transduction. Data represent mean ± standard deviations of three independent experiments. (***) P < 0.001. (B) Growth curves of PHB2-deficient and control MEFs. Cells (5 × 104) were plated on 60-mm dishes and Cre-transduced when indicated. Triplicates of cell samples were counted per time point. (**) P < 0.01; (***) P < 0.001. (C) TUNEL staining of Phb2fl/fl MEFs treated with Cre-recombinase when indicated. DNase I-treated MEFs were analyzed in parallel for control. Bar, 10 μm. (D) Cre-induced expression of Phb2 in Phb2-deficient MEFs. Phb2fl/fl MEFs were stably transfected with the CAGs–NeoR–STOP–IRES–EGFP constructs harboring the Phb2 cDNA (Phb2fl/fl::Phb2). Cre-mediated recombination results in the inactivation of the endogenous, floxed Phb2 alleles and, simultaneously, in the removal of the floxed transcriptional STOP cassette, allowing expression of the Phb2 transgene under control of the CAGs promoter. IRES-EGFP expression was used as a reporter. (E) Caspase activation in Phb2fl/fl and Phb2fl/fl::Phb2 cells in the presence of etoposide. Cell lines were transduced with Cre-recombinase when indicated and treated for 5 h with increasing concentrations of etoposide (0, 0.5, 1, 5, 10, 15 μM). Cell lysates were analyzed by SDS-PAGE and immunoblotting using antibodies directed against caspase-3, PARP, and PHB2. β-Actin was used as a loading control. (F) Caspase activation in Phb2fl/fl and Phb2fl/fl::Phb2 cells by various intrinsic and extrinsic apoptotic stimuli. After Cre-transduction, cells were treated with staurosporine (STS, 1 μM), actinomycin D (ActD, 1 μg/mL), or TNF-α (10 ng/mL) for 5 h. Cell lysates were analyzed as in E. (G) Cytochrome c release from prohibitin-deficient mitochondria in the presence of actinomycin D. Cells transduced with Cre-recombinase when indicated were cultivated in the presence or absence of actinomycin D (1 μg/mL) for 5 h and analyzed by immunofluorescence. Nuclear DNA was stained with DAPI. Bar, 10 μm. (H) Quantification of cytochrome c release from prohibitin-deficient mitochondria. Data represent mean ± standard deviation of three independent experiments. Approximately 300 cells of each type were analyzed. (***) P < 0.001.

TUNEL staining of PHB2-deficient cells, immunoblotting of cell lysates for activated caspase-3, and cytochrome c immunofluorescence did not provide any evidence for spontaneous apoptosis (Fig. 2C–H). Bax and Bcl2 as well as the anti-apoptotic protein Hax1 accumulated at similar levels in wild-type and PHB2-deficient cells (Supplemental Fig. S2). However, Phb2−/− cells exhibited an increased susceptibility toward various intrinsic and extrinsic apoptotic stimuli (Fig. 2E–H; Supplemental Fig. S2). Activated caspase-3 and cleaved PARP accumulated in PHB2-deficient but not in wild-type MEFs treated with various stimuli of the intrinsic pathway of apoptosis, including etoposide, staurosporine, and actinomycin D (Fig. 2E,F). Notably, the absence of PHB2 affected also the extrinsic pathway of apoptosis induced by TNFα (Fig. 2F). In agreement with these findings, cytochrome c was released from mitochondria of PHB2-deficient but not Phb2fl/fl cells after stimulation with limited concentrations of actinomycin D (Fig. 2G,H).

We established stable Phb2fl/fl cell lines that harbor PHB2 downstream from a stop-cassette with flanking loxP sites (Fig. 2D). Expression of transgenes can be induced by Cre-transduction of these cells, which results concomitantly in the deletion of genomic Phb2. Expression of PHB2 in Phb2−/− cells restored cell proliferation (Fig. 2A), cell growth (Fig. 2B), and the apoptotic resistance of the cells (Fig. 2E–H), demonstrating that both phenotypes can be solely attributed to the loss of PHB2. We therefore conclude that deletion of murine Phb2 impairs cell proliferation without inducing apoptosis but renders MEFs highly susceptible to apoptotic stimuli.

Cell proliferation depends on mitochondrial targeting of PHB2

Given the pleiotropic functions that have been suggested for prohibitins in different cellular compartments, we examined whether cellular defects of Phb2−/− cells are caused by the loss of PHB2 within mitochondria. We first replaced conserved arginine residues in the N-terminal mitochondrial targeting sequence of PHB2 (Fig. 3A; Kasashima et al. 2006) and analyzed mitochondrial targeting of the PHB2 variants both in vitro and in vivo. 35S-labeled wild-type PHB2 was imported into mitochondria isolated from murine liver and accumulated in a protease-protected form (Fig. 3B). Import of PHB2 depends on a membrane potential across the inner membrane and is not accompanied by proteolytic cleavage (Fig. 3B). Replacement of single positively charged amino acids at position 11, 17, or 24 by alanine did not affect import of PHB2 in vitro; however, it was severely impaired upon mutation of two arginine residues at positions 11 and 17 (PHB2AARR) (Fig. 3C). Similarly, import of a quadruple mutant containing two additional mutations of arginine residues at positions 48 and 54 was blocked in vitro (PHB2AAAA) (Fig. 3C). When transiently expressed as an EGFP fusion protein in MEFs, mitochondrial targeting of PHB2AARR was still observed, most likely as a consequence of overexpression of the mutant variant (Fig. 3D). Similarly, PHB2RRAA-EGFP targeted mitochondria when transiently expressed in MEFs (Fig. 3D). In contrast, PHB2AAAA-EGFP accumulated in the cytosol, demonstrating that mitochondrial sorting is inhibited in vivo (Fig. 3D).

An external file that holds a picture, illustration, etc. Object name is 476fig3.jpg

Cell proliferation depends on mitochondrial targeting of PHB2. (A) N-terminal amino acids of murine PHB2. Residues highly conserved among prohibitins are shown in black, and homologous amino acids are shown in gray. Arginine residues replaced by alanine at positions 11, 17, 48, and 54 of PHB2 are shown. The N terminus of PHB2ΔN44 is indicated by an arrowhead. (B) Membrane potential-dependent import of PHB2 into mitochondria. PHB2 was synthesized in a cell-free system in the presence of 35S-methionine and imported for 30 min at 25°C into isolated murine liver mitochondria. The membrane potential across the inner membrane was dissipated by adding valinomycin prior to (−ΔΨ) or after completion (+ΔΨ) of import. Nonimported preproteins were degraded by trypsin treatment (50 μg/mL). The samples were analyzed by SDS-PAGE and autoradiography. Input corresponds to 10%. (C) Import of PHB2 mutant variants into isolated mitochondria. Import experiments using 35S-labeled PHB2 and mutant variants were performed as described in B. Import reactions were quantified by PhosphorImaging analysis. (D) Mitochondrial targeting of PHB2 variants in vivo. MEFs were transfected with EGFP-tagged murine PHB2 and mito-DsRed and analyzed by fluorescence microscopy. PHB2 hybrid proteins carrying mutations at the positions indicated are schematically shown. Bar, 10 μm. (E) Proliferation of stable cell lines expressing PHB2 variants monitored by 3H-thymidine incorporation. Stable cell lines expressing PHB2 mutants (as in D) and IRES-EGFP were established as described in Figure 2D. Data represent mean values ± standard deviation of three independent experiments. (F) Immunoblot analysis of MEF cell lines expressing PHB2 or mutant variants thereof. Cell extracts were analyzed by SDS- PAGE and immunoblotting using PHB1- and PHB2-specific antibodies. The α-subunit of the F1 particle of complex V (Suα) was used as a loading control. (G) RT–PCR analysis of Phb1 and Phb2 transcripts in various MEF cell lines. Phb2 transcripts derived from the genomic locus (Phb2) and the transgene (Phb2*) were amplified using allele-specific primer pairs. Transcripts of Gapdh were used as control.

To examine the activity of the PHB2 variants, we established stable Phb2fl/fl cell lines allowing the expression of PHB2AARR, PHB2RRAA, and PHB2AAAA transgenes upon Cre-mediated recombination (see Fig. 2D). Cell proliferation of PHB2-deficient MEFs was restored by transgenic expression of PHB2AARR or PHB2RRAA (Fig. 3E), which accumulated at similar levels as PHB2 in Phb2fl/fl cells (Fig. 3F; data not shown). In contrast, expression of the cytosolic variant PHB2AAAA did not support cell proliferation (Fig. 3E). Although expressed (Fig. 3G), neither mitochondrial PHB1 nor cytosolic PHB2AAAA accumulated stably in these cells, indicating degradation of both proteins (Fig. 3F). On the other hand, mutations in a putative nuclear localization signal and a nuclear receptor box motif did not interfere with cell proliferation (Supplemental Fig. S3). These results reveal a striking correlation between mitochondrial targeting and the maintenance of cell proliferation, pointing to a crucial role of PHB2 within mitochondria.

PHB2 is required for maintenance of tubular mitochondria and normal cristae morphology

To examine the morphology of PHB2-deficient mitochondria, we expressed mitochondria-targeted red fluorescent protein in Phb2+/+, Phb2fl/+, Phb2fl/fl, and in a Phb2fl/fl cell line complemented with Phb2. Ablation of Phb2 by Cre-transduction had severe effects on mitochondrial morphology and led to fragmentation of mitochondria in >90% of Phb2−/− cells (Fig. 4A,B). Fragmented mitochondria were not observed in Phb2+/+ or Phb2fl/+ cells, excluding deleterious effects of Cre-recombinase on mitochondrial morphology (Fig. 4A,B). Cre-mediated expression of Phb2 in Phb2−/− cells restored the tubular morphology of mitochondria (Fig. 4A,B).

An external file that holds a picture, illustration, etc. Object name is 476fig4.jpg

Defective cristae morphogenesis in Phb2−/− cells. (A) Fragmentation of mitochondria in prohibitin-deficient MEFs. Cell lines were transfected with mito-DsRed, treated with Cre-recombinase when indicated, and analyzed after 72 h by fluorescence microscopy. Bar, 10 μm. (B) Quantification of mitochondrial morphology in control (Phb2fl/fl::Phb2) and prohibitin-deficient MEFs. Cells containing tubular (white bars) or fragmented (black bars) mitochondria were classified. More than 200 cells were scored per experiment. (C) Defective mitochondrial ultrastructure in Phb2−/− cells. Representative transmission electron micrographs of mitochondria in the following cell lines are shown: Phb2fl/fl (panel a), Phb2fl/+ +Cre (panel b), Phb2fl/fl::Phb2 +Cre (panel c), and Phb2fl/fl +Cre (panels d–g). Bar, 500 nm. (D) Quantification of cristae morphology in Phb2fl/fl, Phb2fl/fl::Phb2, and Phb2fl/fl MEFs transduced with Cre-recombinase when indicated. Approximately 50% of cells with disorganized cristae morphology contain vesicular cristae structures. Approximately 100 sections of individual cells were scored per experiment. (E) Three-dimensional reconstructions from serial transmission electron microscopy sections of Phb2fl/fl cells (panel a) transduced with Cre-recombinase (panel b). Bar, 500 nm.

The ultrastructure of mitochondria in Cre-transduced Phb2fl/+, Phb2fl/fl, and Phb2fl/fl::Phb2 MEFs was examined by electron microscopy (Fig. 4C,D). The presence of loxP-flanked Phb2 or the deletion of Phb2 in heterozygous Phb2fl/+ cells did not affect the ultrastructure of mitochondria (Fig. 4C, panels a,b). However, a large fraction of mitochondria in Phb2−/− cells harbored defective cristae (Fig. 4C [panels d–g], D). Either lamellar cristae were almost completely lost or balloon-like, vesicular structures were detected within mitochondria (Fig. 4C, panels d–g). This effect was largely reversed upon expression of PHB2 in Phb2−/− cells (Fig. 4C [panel c], D).

To obtain high-resolution images of the three-dimensional organization of mitochondria, we analyzed serial ultrathin sections of Phb2fl/fl and Phb2−/− cells by transmission electron microscopy (Fig. 4E). Three-dimensional models generated from these images revealed the presence of regular lamellar cristae in Phb2fl/fl cells (Fig. 4E). In contrast, morphologically distinct vesicular structures were observed to accumulate within mitochondria of PHB2-deficient cells (Fig. 4E). We conclude that the formation of lamellar mitochondrial cristae depends on PHB2.

PHB2 controls cleavage of OPA1 in the inner membrane

The dynamin-like GTPase OPA1 is required for both the maintenance of normal cristae in the inner membrane and cristae remodeling during mitochondria-mediated apoptosis (Olichon et al. 2003; Griparic et al. 2004; Frezza et al. 2006). It is therefore conceivable that deletion of Phb2 affects OPA1 function. Expression of eight OPA1 splice variants and proteolytic processing leads to the formation of at least five different isoforms of OPA1, two long forms designated L1 and L2, which can be proteolytically converted to three short forms, designated S3–S5 (Ishihara et al. 2006; Duvezin-Caubet et al. 2007; Griparic et al. 2007; Olichon et al. 2007; Song et al. 2007). Immunoblotting of Phb2−/− and Phb2−/−::Phb2 cells with OPA1-specific antibodies revealed drastic alterations in the pattern of OPA1 isoforms accumulating in the absence of PHB2 (Fig. 5A). While the long forms L1 and L2 and the short form S4 were absent or hardly detectable, S3 and, more pronounced, S5 accumulated in cells lacking PHB2 (Fig. 5A). These alterations were reversed in Phb2−/− cells complemented by PHB2 (Fig. 5A).

An external file that holds a picture, illustration, etc. Object name is 476fig5.jpg

PHB2 controls cleavage of OPA1 but does not affect respiratory activities. (A) Immunoblot analysis of Phb2fl/fl and Phb2fl/fl::Phb2 cells transduced with Cre-recombinase. Cell lysates were analyzed by SDS-PAGE and immunoblotting using OPA1-specific, PHB1-specific, PHB2-specific, and, for control, β-actin-specific antibodies. (B) Maintenance of mitochondrial membrane potential in prohibitin-deficient MEFs. The cell lines indicated were stained with the fluorescent dye JC-1 and analyzed by flow cytometry at 590 nm. Dissipation of the membrane potential with CCCP and unstained cells were used as controls. (C) Oxygen consumption in permeabilized control (n = 5; white bars) and Phb2−/− MEFs (n = 3; black bars) after Cre-mediated inactivation of Phb2 under conditions of substrate-driven respiration. Data represent mean value ± standard deviations. (D) Relative activities of respiratory chain and TCA cycle enzymes in control (n = 5, white bars) and Phb2−/− MEFs (n = 4, black bars) after Cre-mediated inactivation of Phb2. (CII) Succinate quinone dichlorophenol indophenol reductase; (CII + CIII) succinate cytochrome c reductase; (CIII) decylubiquinol cytochrome c reductase; (CIV) cytochrome c oxidase; (CS) citrate synthase; (IDH) isocitrate dehydrogenase. Data represent mean value ± standard deviation.

Mitochondrial dysfunction and the dissipation of the membrane potential across the inner membrane can induce OPA1 processing and mitochondrial fragmentation (Duvezin-Caubet et al. 2006; Ishihara et al. 2006) and may cause the accumulation of S-OPA1 in the absence of PHB2. We therefore assessed the mitochondrial membrane potential in Phb2−/− cells by JC-1 staining and fluorescence-activated cell sorting (Fig. 5B). The membrane potential was maintained in PHB2-deficient cells (Fig. 5B). Moreover, neither cellular ATP levels nor cellular oxygen consumption and the enzymatic activities of respiratory complexes in the inner membrane were affected in the absence of PHB2 (Fig. 5C,D; Supplemental Fig. S5). Thus, the accelerated processing of OPA1 in PHB2-deficient cells is not caused by an impaired membrane potential or respiratory activity.

Deficiencies in Phb2−/− cells are caused by the loss of L-OPA1

The selective loss of L-OPA1 in PHB2-deficient cells may explain both the accumulation of aberrant mitochondria and the increased susceptibility of Phb2−/− cells toward apoptotic stimuli. To examine this possibility, we transiently expressed in Phb2fl/fl cells a Flag-tagged isoform 1 of OPA1 that cannot be cleaved as amino acid residues flanking the processing site had been deleted (L-OPA1Δ) (Ishihara et al. 2006). In parallel, a Flag-tagged hybrid protein composed of the short form of OPA1 (amino acids 230–997) fused to the mitochondrial targeting sequence of AIF (amino acids 1–95; S-OPA1) was transiently expressed in Phb2fl/fl cells (Fig. 6A). Phb2 was deleted by Cre-transduction, and the expression of the OPA1 variants was monitored by immunoblot analysis (Fig. 6B). A long isoform of OPA1 was detected in cells upon transfection of L-OPA1Δ that was absent in PHB2-deficient control cells (Fig. 6B). After coexpression of mitochondria-targeted red fluorescent protein with L- and S-OPA1 in Phb2−/− cells, the morphology of mitochondria was assessed by fluorescence microscopy. While ~90% of PHB2-deficient cells contained fragmented mitochondria, expression of L-OPA1Δ restored tubular mitochondria in ~50% of the cells (Fig. 6C,D). Expression of S-OPA1, on the other hand, did not significantly affect the morphology of mitochondria (Fig. 6C,D).

An external file that holds a picture, illustration, etc. Object name is 476fig6.jpg

Expression of L-OPA1Δ restores mitochondrial morphology in Phb2−/− cells. (A) Flow chart for complementation experiments using OPA1 variants. MEFs were transiently transfected twice within 4 h with plasmids indicated and subjected to Cre-transduction. After incubation for a further 72 h, cells were analyzed by immunoblotting and fluorescence microscopy. (B) Immunoblot analysis of Phb2fl/fl MEFs transfected with plasmids and transduced with Cre-recombinase as indicated. Endogenous OPA1 isoforms and transfected Flag-tagged OPA1 variants were detected with OPA1- and Flag-specific antibodies, respectively. The arrow indicates the presence of the L-OPA1Δ in PHB2-depleted MEFs after transfection. β-Actin was used as a loading control. (C) Restoration of tubular mitochondria in prohibitin-deficient MEFs upon expression of L-OPA1Δ. Phb2fl/fl cells complemented with PHB2 when indicated were transfected with mito-DsRed and the indicated plasmids, treated with Cre-recombinase, and analyzed after 72 h by fluorescence microscopy. Bar, 10 μm. (D) Quantification of mitochondrial morphology in prohibitin-deficient MEFs transfected with mito-DsRed and OPA1 variants. Cells containing tubular (black bars) or fragmented (white bars) mitochondria were classified. More than 200 cells were scored in three independent experiments. (**) P < 0.01. Error bars indicate ±standard deviations. (E) Restoration of cristae morphology in Phb2−/− cells upon expression of L-OPA1Δ. MEFs were transfected with the indicated plasmids, and mitochondrial morphology was assessed by transmission electron microscopy. Bar, 500 nm. (F) Quantification of deficiencies in cristae morphology in Phb2−/− cells upon expression of S-OPA1 and L-OPA1Δ. Approximately 100 sections of individual cells were scored per experiment. (***) P < 0.001. Error bars indicate standard deviations.

Next, we analyzed the ultrastructure of mitochondria by electron microscopy of Phb2−/− cells that expressed PHB2, S-OPA1, or L-OPA1Δ. Expression of PHB2 restored normal cristae morphology in >90% of Phb2−/− cells (Fig. 6E,F). Strikingly, mitochondrial cristae were also maintained in ~55% of Phb2−/− cells expressing L-OPA1Δ (Fig. 6E,F). In contrast, aberrant mitochondria lacking cristae and containing vesiculated inner membrane structures were formed in Phb2−/− cells regardless of the presence of S-OPA1 in these cells (Fig. 6E,F). We conclude that the long variant of the OPA1 isoform 1 is sufficient to maintain tubular mitochondria and normal cristae in the absence of PHB2. It should be noted that expression of L-OPA1Δ appears to substitute for the loss of both L1 and L2 isoforms, indicating functional redundancy. Taken together, the aberrant morphogenesis of mitochondria in PHB2-deficient cells is solely caused by the absence of long OPA1 isoforms.

In further experiments, we examined whether expression of L-OPA1Δ also restores the apoptotic resistance of Phb2−/− cells. After transient expression of L-OPA1Δ or S-OPA1 in Phb2fl/fl cells and deletion of Phb2 by Cre-transduction, apoptosis was stimulated by actinomycin D (Fig. 7A). Cells expressing OPA1 variants were identified by cotransfection with mitochondria-targeted DsRed, which enabled us to monitor mitochondrial morphology and cytochrome c release in the same cells. Expression of S-OPA1 did not prevent mitochondrial fragmentation upon Phb2 deletion (see also Fig. 6) nor the release of cytochrome c from PHB2-deficient mitochondria in the presence of actinomycin D (Fig. 7B–D). In contrast, expression of L-OPA1Δ restored tubular mitochondria and inhibited to a large extent cytochrome c release in the presence of actinomycin D (Fig. 7B–D). Thus, stabilization of L-OPA1 by PHB2 protects cells against apoptosis.

An external file that holds a picture, illustration, etc. Object name is 476fig7.jpg

The loss of L-OPA1 renders Phb2−/− cells susceptible toward apoptosis. (A) Flow chart for complementation experiments using OPA1 variants. Phb2−/− cells were transiently transfected twice within 4 h with plasmids indicated and subjected to Cre-transduction. After a further incubation for 72 h, cells were cultivated in the presence of actinomycin D (1 μg/mL), and induction of apoptosis was assessed monitoring cytochrome c release and caspase activation. (B) Restoration of apoptotic resistance of Phb2−/− cells upon expression of L-OPA1Δ. After Cre-transduction of Phb2fl/fl cells and transfection of plasmids encoding S-OPA1 or L-OPA1Δ as indicated, cytochrome c release was monitored by immunofluorescence using cytochrome c-specific antibodies. Nuclear DNA was stained with DAPI. Representative images are shown. Bar, 10 μm. (C) Quantification of cytochrome c release from prohibitin-deficient mitochondria supplemented with S-OPA1 or L-OPA1Δ and stimulated with actinomycin D. Approximately 300 cells were counted for each genotype in three independent experiments. (**) P < 0.01. (D) Quantitative assessment of mitochondrial morphology in prohibitin-deficient cells supplemented with S-OPA1 or L-OPA1Δ and stimulated with actinomycin D. Tubular mitochondria in cells transfected with vector (white bars), S-OPA1 (gray bars), or L-OPA1Δ (black bars) were classified. Approximately 300 cells were scored for each genotype in three independent experiments. (**) P < 0.01. (E) Expression of L-OPA1Δ promotes proliferation of Phb2−/− cells. Growth of prohibitin-deficient MEFs was monitored after transfection of S-OPA1 and L-OPA1Δ by determining the incorporation of 3H-thymidine into DNA. Data represent the mean ± standard deviation of four independent experiments. (*) P < 0.05; (**) P < 0.01.

These results identify the control of OPA1 cleavage as the central function of prohibitins within mitochondria. As cell proliferation depends on mitochondria-targeted PHB2, it is conceivable that the proliferation defect of PHB2-deficient cells is a direct consequence of the impaired processing of OPA1 within mitochondria as well. We therefore performed 3H-thymidine DNA labeling experiments in Phb2−/− cells transiently expressing S-OPA1 and L-OPA1Δ (Fig. 7E). While the presence of S-OPA1 did not improve proliferation of Phb2−/− cells, we observed a partial but statistically significant restoration of cell proliferation upon expression of L-OPA1Δ (Fig. 7E). These findings indicate that the absence of L-OPA1 and defects in mitochondrial morphology deteriorate the proliferation of PHB2-deficient cells.

Discussion

We used conditional gene targeting of Phb2 in MEFs to define cellular activities of prohibitins. PHB2 ensures cell proliferation, acts anti-apoptotic, and maintains normal cristae morphology. As PHB1 and PHB2 are functionally interdependent, cellular defects observed in Phb2−/− cells can be attributed to the loss of the assembled prohibitin complex. Complementation assays restrict its function to mitochondria and identify the processing of the dynamin-like GTPase OPA1 in the inner membrane as the central cellular process controlled by prohibitins.

The fragmented mitochondria harboring highly disorganized and swollen cristae in prohibitin-deficient cells strikingly resemble mitochondria that were observed upon down-regulation of OPA1 (Olichon et al. 2003; Griparic et al. 2004). Our experiments in prohibitin-deficient mitochondria ascribe these phenotypes to the selective loss of L-OPA1 isoforms and are therefore consistent with recent findings demonstrating the requirement of both L-OPA1 and S-OPA1 for mitochondrial fusion (Song et al. 2007). Moreover, the absence of L-OPA1 explains the increased susceptibility of Phb2−/− cells to apoptosis. To facilitate cytochrome c release from the intermembrane space, mitochondrial cristae are restructured at early stages of apoptosis, a process controlled by OPA1 (Frezza et al. 2006). A current model suggests that a complex containing L-OPA1 and S-OPA1 controls mitochondrial cristae junctions and prevents the redistribution of cytochrome c from the cristal lumen to the peripheral intermembrane space (Frezza et al. 2006). Accordingly, the loss of L-OPA1 in Phb2−/− cells might facilitate cytochrome c release from intracristal compartments. However, alternative models are also conceivable. A recent tomographic analysis of mitochondrial transformation during apoptosis suggests that cristae remodeling is not required for efficient cytochrome c release (Sun et al. 2007). Energized mitochondria containing vesicular intramitochondrial structures have been observed in HeLa cells shortly after induction of apoptosis and cytochrome c release (Sun et al. 2007). This is highly reminiscent of Phb2−/− cells, which are fully energized and not apoptotic but more susceptible to apoptotic stimuli. It therefore appears that pre-existing ultrastructural mitochondrial alterations in Phb2−/− cells cause the facilitated progression of the apoptotic program after stimulation, which is required to trigger cytochrome c release. Consistently, expression of L-OPA1 substitutes for the absence of prohibitins and protects prohibitin-deficient cells against apoptosis, demonstrating that PHB2 exerts its anti-apoptotic function via OPA1. It remains to be established, however, how an altered cristae morphology due to loss of L-OPA1 triggers an increased sensitivity of mitochondria to outer membrane permeabilization. Notably, we did not observe an anti-apoptotic effect of S-OPA1 that has been described previously (Cipolat et al. 2006). This apparent discrepancy could be explained by the absence of L-OPA1 in Phb2−/− cells used in this study, while S-OPA1 was overexpressed in wild-type fibroblasts in previous experiments (Cipolat et al. 2006). It therefore appears likely that S-OPA1 exerts its anti-apoptotic effect only in complex with L-OPA1.

Our complementation experiments in Phb2−/− MEFs restrict the function of prohibitins to mitochondria and did not provide any evidence for nonmitochondrial activities. The proliferation of Phb2−/− cells is only restored upon expression of mitochondrially targeted PHB2, assigning a crucial role for cell proliferation to mitochondria-localized prohibitins. Expression of L-OPA1Δ not only restored mitochondrial morphogenesis in Phb2−/− cells and their resistance to apoptosis, but also promoted the proliferation of prohibitin-deficient MEFs. These findings directly link growth deficiencies of Phb2−/− cells to defects in mitochondrial morphogenesis. How an impaired morphology of mitochondria impacts on cell proliferation remains to be determined. Cellular ATP levels and respiration were not grossly affected in the absence of prohibitins, indicating that mitochondria control cell proliferation independent of their function for cellular energy metabolism.

How do prohibitins affect the processing of OPA1 within mitochondria? OPA1 cleavage correlates with the energy status of mitochondria and is induced upon apoptosis (Duvezin-Caubet et al. 2006; Baricault et al. 2007). However, deletion of Phb2 did not affect the mitochondrial membrane potential or respiratory activity, nor do PHB2-deficient cells undergo apoptosis in the absence of stimuli, indicating that OPA1 cleavage is under direct control by prohibitins. As deficiencies of Phb2−/− cells can be rescued by L-OPA1, a role of prohibitins for the biogenesis or folding of OPA1 appears unlikely. Rather, the loss of L-OPA1 and accumulation of S-OPA1 isoforms in Phb2−/− cells indicates that L-OPA1 isoforms are destabilized and processing is facilitated in the absence of PHB2. This is reminiscent of findings in yeast where deletion of prohibitin genes results in an accelerated proteolysis of nonassembled inner membrane proteins by the m-AAA protease (Steglich et al. 1999). Large assemblies of prohibitins and m-AAA proteases are present in the mitochondrial inner membrane (Steglich et al. 1999). Moreover, reconstitution experiments in yeast revealed that various mammalian m-AAA protease isoenzymes are able to cleave OPA1 (Duvezin-Caubet et al. 2007). Notably, several peptidases appear to regulate OPA1 cleavage at different sites (Cipolat et al. 2006; Ishihara et al. 2006; Duvezin-Caubet et al. 2007; Griparic et al. 2007; Song et al. 2007). In contrast to other OPA1 isoforms, S4 appears to be generated by the i-AAA protease Yme1L (Griparic et al. 2007; Song et al. 2007). It accumulates at decreased levels absent in Phb2−/− cells, suggesting that prohibitins may regulate the cleavage of OPA1 by various peptidases.

We propose that prohibitins serve as scaffolds in the inner membrane and define the spatial organization of components that control the stability and processing of OPA1 and coordinate membrane fusion. Ring-like prohibitin complexes may sequester OPA1 and recruit m-AAA proteases to membrane domains involved in the fusion process. Considering the sequence similarity of prohibitins to lipid raft-associated proteins (Tavernarakis et al. 1999; Langhorst et al. 2005; Morrow and Parton 2005), prohibitins may also promote the lateral segregation of membrane lipids resulting in the formation of lipid microdomains. Surrounding membrane lipids are likely to affect the vectorial membrane dislocation of OPA1 or the proteolytic activity of m-AAA proteases. Moreover, increasing evidence points to an important role of lipids and lipid microdomains in various cellular fusion events (Fratti et al. 2004; Altmann and Westermann 2005; Boukh-Viner et al. 2005; Choi et al. 2006) and apoptotic processes (Choi et al. 2007). The identification of prohibitins as regulators of mitochondrial cristae morphology now paves the way for a detailed understanding of the role of spatial membrane organization for the morphogenesis and function of mitochondria.

Materials and methods

Generation of conditional Phb2 mice

A targeting vector for the conditional allele of murine Phb2 was generated by insertion of a 1.4-kb genomic fragment containing exons 3 and 4 between two loxP sites of the pRAPIDflirt vector (A. Bruehl and A. Waisman, unpubl.). An upstream 2.2-kb fragment and a 4.5-kb downstream fragment were used as homology arms. Additionally, the targeting construct contained an FRT-flanked PGKneoR cassette and the Herpes Simplex Virus thymidine kinase gene (HSV-TK) for positive and negative selection, respectively. The final construct was linearized by SwaI digestion prior to transfection.

Bruce-4 ES cells (Kontgen et al. 1993) derived from C57BL/6 mice were transfected, cultured, and selected as described previously (Kuhn and Torres 2002). G418- and gancyclovir-resistant ES cell colonies were screened by Southern blotting using external and internal genomic probes (Supplemental Fig. S1).

Chimeric mice were generated by injection of Phb2fl(neo)/+ ES cells into blastocysts from CB20 mice. Matings of male chimeras to C57BL/6 females resulted in germline transmitted offspring of pure C57BL/6 genetic background.

In vivo deletion of the FRT-flanked PGKneoR cassette yielding Phb2fl/+ mice was achieved by crossing male germline transmitted mice with FLPe-deleter mice (Rodriguez et al. 2000). Phb2fl/+ mice were intercrossed to obtain the homozygous Phb2fl/fl strain. Heterozygous PHB2-deficient mice were generated by crossing Phb2fl/+ mice to the Cre-Deleter strain (Schwenk et al. 1995). Mice were genotyped by PCR using genomic DNA isolated from tail biopsies. PCR primer sequences are available upon request. Care of all animals was within institutional animal care committee guidelines.

Cloning procedures

Phb2 was PCR-amplified from C57BL/6 mouse liver cDNA and subcloned. Mutations were introduced using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). For cell-free synthesis of PHB2, Phb2 was cloned into pGEM4 (Promega) allowing expression by SP6-RNA polymerase. Full-length and truncated Phb2 were cloned into pEGFP-N3 (Clontech) to produce C-terminal in-frame fusions with EGFP.

To obtain Cre-inducible expression plasmids allowing the generation of stable cell lines (pCAGs–STOP–IRES–EGFP), we inserted a chicken β-actin promoter (CAGs) into the PacI site of pSTOP–IRES–EGFP (Sasaki et al. 2006) and subcloned Phb2 and mutant variants.

Transduction of MEFs with Cre-recombinase

Recombinant His-TAT-NLS-Cre (HTNC) fusion protein was expressed and purified as described previously (Peitz et al. 2002). HTNC was diluted in DMEM/PBS to a final concentration of 3–5 μM, sterile-filtered, and applied to MEFs grown in cell culture dishes. Cells were incubated for 20 h, washed with PBS, and supplemented with growth medium. The efficiency of recombination was assessed by Phb2 allele-specific PCR.

Assessment of cell proliferation

MEFs (1 × 106) were transduced with Cre-recombinase and collected by trypsinization after 60 h. Onto 96-well tissue culture plates, 1 × 104 cells were seeded per well and labeled for 12 h (1 μCi of 3H-thymidine per well). MEFs were harvested and spotted onto glass fiber filters. Incorporated 3H-thymidine was determined with a microplate scintillation β-counter.

Fluorescence microscopy

For Phb2 localization studies, 1 × 105 MEFs were plated on glass coverslips and transfected with the indicated plasmids using Lipofectamine 2000 (Invitrogen). Forty-eight hours after transfection, cells were fixed in 4% p-formaldehyde and stained with DAPI. Images were acquired using a Zeiss Axioplan microscope and processed with the AxioVision software (Zeiss).

Mitochondrial morphology was examined by transfection of mito-DsRed or pEYFP-mito (Clontech) using GeneJuice transfection reagent (Merck Biosciences). MEFs (2 × 105) were plated on coverslips and transfected twice with the indicated plasmids. Mitochondrial morphology was analyzed using the DeltaVision microscope system. Twenty-five stacks were acquired and subjected to deconvolution.

Cytochrome c release was monitored by immunofluorescence microscopy. MEFs (2 × 105) were grown on coverslips, transfected twice, and transduced with Cre-recombinase. MEFs were treated with actinomycin D (1 μg/mL) for 5 h and fixed in 4% p-formaldehyde, followed by permeabilization with 0.15% Triton X-100 in phosphate-buffered saline (PBS) for 15 min. After incubation for 1 h in blocking buffer (3% bovine serum albumine in PBS), cells were treated for 12 h with α-cytochrome c antibody (BD Biosciences). MEFs were washed three times for 5 min each with blocking buffer, incubated for 2 h with Alexa Fluor 488 α-mouse secondary antibody (Molecular Probes), and stained with DAPI. After three washing steps for 5 min each with blocking buffer, cells were mounted and images were acquired using a DeltaVision microscope system.

Transmission electron microscopy

MEFs (2 × 105) were plated on glass coverslips (thickness 0.2 mm), transfected, Cre-transduced, and flat-embedded for transmission electron microscopy as follows: After 72 h, cells were fixed in 0.1 M HEPES/KOH (pH 7.2), 4 mM CaCl2, and 2.5% glutaraldehyde for 4 h at room temperature. After three rinses with 0.1 M HEPES/KOH (pH 7.2), 4 mM CaCl2, cells were post-fixed in 1% osmium tetroxide for 45 min at 4°C, rinsed three times in distilled water, and incubated in 1% uranyl acetate for 1 h at 4°C. Dehydration of the samples in a graduated ethanol series, infiltration with Epon, and flat embedding was performed according to standard procedures. Ultrathin sections (40–70 nm) were cut and mounted on pioloform-coated copper grids (Plano). Sections were stained with lead citrate and uranyl acetate and viewed with a Zeiss CEM 902 transmission electron microscope (Carl Zeiss) at 80 kV. Micrographs were taken using EMS EM film (Maco). Three-dimensional reconstructions were prepared from scanned films using IMOD software, version 3.5.5 (Kremer et al. 1996).

Cell death analysis

For TUNEL staining, 1 × 105 MEFs were grown on glass coverslips in six-well plates, treated with Cre-recombinase when indicated, and cultured for 72 h. Cells were fixed in 4% p-formaldehyde for 10 min and washed in PBS, and TUNEL staining was performed using the DeadEnd Fluorometric TUNEL system (Promega).

MEFs (2 × 106) were transfected twice, transduced with Cre-recombinase, and further cultivated for 72 h. To stimulate the induction of apoptosis, cells were treated with TNFα (20 ng/mL and 2.5 μg/mL cycloheximide), etoposide (10 μM), actinomycin D (1 μg/mL), or staurosporine (1 μM) for 5 h, and cell lysates were analyzed by immunoblotting.

Acknowledgments

We thank K. Mihara for OPA1 expression plasmids and Gudrun Zimmer for expert technical assistance. This work was supported by grants of the Deutsche Forschungsgemeinschaft, the European Union (6th Framework Programme), and the German-Israeli-Project (DIP grant F.5.1) to T.L.

Footnotes

Supplemental material is available at http://www.genesdev.org.

Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.460708

References

  • Alexander C., Votruba M., Pesch U.E., Thiselton D.L., Mayer S., Moore A., Rodriguez M., Kellner U., Leo-Kottler B., Auburger G., et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 2000;26:211–215. [Abstract] [Google Scholar]
  • Altmann K., Westermann B. Role of essential genes in mitochondrial morphogenesis in Saccharomyces cerevisiae. Mol. Biol. Cell. 2005;16:5410–5417. [Europe PMC free article] [Abstract] [Google Scholar]
  • Back J.W., Sanz M.A., De Jong L., De Koning L.J., Nijtmans L.G., De Koster C.G., Grivell L.A., Van Der Spek H., Muijsers A.O. A structure for the yeast prohibitin complex: Structure prediction and evidence from chemical crosslinking and mass spectrometry. Protein Sci. 2002;11:2471–2478. [Europe PMC free article] [Abstract] [Google Scholar]
  • Baricault L., Segui B., Guegand L., Olichon A., Valette A., Larminat F., Lenaers G. OPA1 cleavage depends on decreased mitochondrial ATP level and divalent metals. Exp. Cell Res. 2007;313:3800–3808. [Abstract] [Google Scholar]
  • Berger K.H., Yaffe M.P. Prohibitin family members interact genetically with mitochondrial inheritance components in Saccharomyces cerevisiae. Mol. Cell. Biol. 1998;18:4043–4052. [Europe PMC free article] [Abstract] [Google Scholar]
  • Birner R., Nebauer R., Schneiter R., Daum G. Synthetic lethal interaction of the mitochondrial phosphatidylethanolamine biosynthetic machinery with the prohibitin complex of Saccharomyces cerevisiae. Mol. Cell. Biol. 2003;14:370–383. [Europe PMC free article] [Abstract] [Google Scholar]
  • Boukh-Viner T., Guo T., Alexandrian A., Cerracchio A., Gregg C., Haile S., Kyskan R., Milijevic S., Oren D., Solomon J., et al. Dynamic ergosterol- and ceramide-rich domains in the peroxisomal membrane serve as an organizing platform for peroxisome fusion. J. Cell Biol. 2005;168:761–773. [Europe PMC free article] [Abstract] [Google Scholar]
  • Browman D.T., Hoegg M.B., Robbins S.M. The SPFH domain-containing proteins: More than lipid raft markers. Trends Cell Biol. 2007;17:394–402. [Abstract] [Google Scholar]
  • Chan D.C. Mitochondria: Dynamic organelles in disease, aging, and development. Cell. 2006a;125:1241–1252. [Abstract] [Google Scholar]
  • Chan D.C. Mitochondrial fusion and fission in mammals. Annu. Rev. Cell Dev. Biol. 2006b;22:79–99. [Abstract] [Google Scholar]
  • Choi S.Y., Huang P., Jenkins G.M., Chan D.C., Schiller J., Frohman M.A. A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis. Nat. Cell Biol. 2006;8:1255–1262. [Abstract] [Google Scholar]
  • Choi S.Y., Gonzalvez F., Jenkins G.M., Slomianny C., Chretien D., Arnoult D., Petit P.X., Frohman M.A. Cardiolipin deficiency releases cytochrome c from the inner mitochondrial membrane and accelerates stimuli-elicited apoptosis. Cell Death Differ. 2007;14:597–606. [Abstract] [Google Scholar]
  • Cipolat S., Rudka T., Hartmann D., Costa V., Serneels L., Craessaerts K., Metzger K., Frezza C., Annaert W., D’Adamio L., et al. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell. 2006;126:163–175. [Abstract] [Google Scholar]
  • Coates P.J., Jamieson D.J., Smart K., Prescott A.R., Hall P.A. The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr. Biol. 1997;7:607–610. [Abstract] [Google Scholar]
  • Coates P.J., Nenutil R., McGregor A., Picksley S.M., Crouch D.H., Hall P.A., Wright E.G. Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp. Cell Res. 2001;265:262–273. [Abstract] [Google Scholar]
  • Delettre C., Lenaers G., Griffoin J.M., Gigarel N., Lorenzo C., Belenguer P., Pelloquin L., Grosgeorge J., Turc-Carel C., Perret E., et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 2000;26:207–210. [Abstract] [Google Scholar]
  • Duvezin-Caubet S., Jagasia R., Wagener J., Hofmann S., Trifunovic A., Hansson A., Chomyn A., Bauer M.F., Attardi G., Larsson N.G., et al. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J. Biol. Chem. 2006;281:37972–37979. [Abstract] [Google Scholar]
  • Duvezin-Caubet S., Koppen M., Wagener J., Zick M., Israel L., Bernacchia A., Jagasia R., Rugarli E.I., Imhof A., Neupert W., et al. Processing of OPA1 reconstituted in yeast depends on the subunit composition of the m-AAA protease. Mol. Biol. Cell. 2007;18:3582–3590. [Europe PMC free article] [Abstract] [Google Scholar]
  • Fratti R.A., Jun Y., Merz A.J., Margolis N., Wickner W. Interdependent assembly of specific regulatory lipids and membrane fusion proteins into the vertex ring domain of docked vacuoles. J. Cell Biol. 2004;167:1087–1098. [Europe PMC free article] [Abstract] [Google Scholar]
  • Frezza C., Cipolat S., de Martins Brito O., Micaroni M., Beznoussenko G.V., Rudka T., Bartoli D., Polishuck R.S., Danial N.N., De Strooper B., et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006;126:177–189. [Abstract] [Google Scholar]
  • Fusaro G., Dasgupta P., Rastogi S., Joshi B., Chellappan S. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J. Biol. Chem. 2003;278:47853–47861. [Abstract] [Google Scholar]
  • Griparic L., van der Wel N.N., Orozco I.J., Peters P.J., van der Bliek A.M. Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J. Biol. Chem. 2004;279:18792–18798. [Abstract] [Google Scholar]
  • Griparic L., Kanazawa T., Van der Bliek A.M. Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavage. J. Cell Biol. 2007;178:757–764. [Europe PMC free article] [Abstract] [Google Scholar]
  • Hoppins S., Lackner L., Nunnari J. The machines that divide and fuse mitochondria. Annu. Rev. Biochem. 2007;76:751–780. [Abstract] [Google Scholar]
  • Ikonen E., Fiedler K., Parton R.G., Simons K. Prohibitin, an antiproliferative protein, is localized to mitochondria. FEBS Lett. 1995;358:273–277. [Abstract] [Google Scholar]
  • Ishihara N., Fujita Y., Oka T., Mihara K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 2006;25:2966–2977. [Europe PMC free article] [Abstract] [Google Scholar]
  • Kasashima K., Ohta E., Kagawa Y., Endo H. Mitochondrial functions and estrogen receptor-dependent nuclear translocation of pleiotropic human prohibitin 2. J. Biol. Chem. 2006;281:36401–36410. [Abstract] [Google Scholar]
  • Kontgen F., Suss G., Stewart C., Steinmetz M., Bluethmann H. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. Immunol. 1993;5:957–964. [Abstract] [Google Scholar]
  • Kremer J.R., Mastronarde D.N., McIntosh J.R. Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 1996;116:71–76. [Abstract] [Google Scholar]
  • Kuhn R., Torres R.M. Cre/loxP recombination system and gene targeting. Methods Mol. Biol. 2002;180:175–204. [Abstract] [Google Scholar]
  • Kurtev V., Margueron R., Kroboth K., Ogris E., Cavailles V., Seiser C. Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases. J. Biol. Chem. 2004;279:24834–24843. [Abstract] [Google Scholar]
  • Langhorst M.F., Reuter A., Stuermer C.A. Scaffolding microdomains and beyond: The function of reggie/flottilin proteins. Cell. Mol. Life Sci. 2005;62:2228–2240. [Europe PMC free article] [Abstract] [Google Scholar]
  • McBride H.M., Neuspiel M., Wasiak S. Mitochondria: More than just a powerhouse. Curr. Biol. 2006;16:551–560. [Abstract] [Google Scholar]
  • Mengwasser J., Piau A., Schlag P., Sleeman J.P. Differential immunization identifies PHB1/PHB2 as blood-borne tumor antigens. Oncogene. 2004;23:7430–7435. [Abstract] [Google Scholar]
  • Mishra S., Murphy L.C., Nyomba B.L.G., Murphy L.J. Prohibitin: A potential target for new therapeutics. Trends Mol. Med. 2005;11:192–197. [Abstract] [Google Scholar]
  • Montano M.M., Ekena K., Delage-Mourroux R., Chang W., Martini P., Katzenellenbogen B.S. An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc. Natl. Acad. Sci. 1999;96:6947–6952. [Europe PMC free article] [Abstract] [Google Scholar]
  • Morrow I.C., Parton R.G. Flotillins and the PHB domain protein family: Rafts, worms and anaesthetics. Traffic. 2005;6:725–740. [Abstract] [Google Scholar]
  • Nijtmans L.G.J., Artal Sanz M., Grivell L.A., Coates P.J. The mitochondrial PHB complex: Roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell. Mol. Life Sci. 2002;59:143–155. [Europe PMC free article] [Abstract] [Google Scholar]
  • Nolden M., Ehses S., Koppen M., Bernacchia A., Rugarli E.I., Langer T. The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell. 2005;123:277–289. [Abstract] [Google Scholar]
  • Nuell M.J., Stewart D.A., Walker L., Friedman V., Wood C.M., Owens G.A., Smith J.R., Schneider E.L., Dell’Arco R., Lumpkin C.K., et al. Prohibitin, an evolutionary conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol. Cell. Biol. 1991;11:1372–1381. [Europe PMC free article] [Abstract] [Google Scholar]
  • Okamoto K., Shaw J.M. Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes. Annu. Rev. Genet. 2005;39:503–536. [Abstract] [Google Scholar]
  • Olichon A., Baricault L., Gas N., Guillou E., Valette A., Belenguer P., Lenaers G. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J. Biol. Chem. 2003;278:7743–7746. [Abstract] [Google Scholar]
  • Olichon A., Elachouri G., Baricault L., Delettre C., Belenguer P., Lenaers G. OPA1 alternate splicing uncouples an evolutionary conserved function in mitochondrial fusion from a vertebrate restricted function in apoptosis. Cell Death Differ. 2007;14:682–692. [Abstract] [Google Scholar]
  • Osman C., Wilmes C., Tatsuta T., Langer T. Prohibitins interact genetically with Atp23, a novel processing peptidase and chaperone for the F1F0-ATP synthase. Mol. Biol. Cell. 2007;18:627–635. [Europe PMC free article] [Abstract] [Google Scholar]
  • Park S.-E., Xu J., Frolova A., Liao L., O’Malley B.W., Katzenellenbogen B.S. Genetic deletion of the repressor of estrogen receptor activity (REA) enhances the response to estrogen in target tissues in vivo. Mol. Cell. Biol. 2005;25:1989–1999. [Europe PMC free article] [Abstract] [Google Scholar]
  • Peitz M., Pfannkuche K., Rajewsky K., Edenhofer F. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: A tool for efficient genetic engineering of mammalian genomes. Proc. Natl. Acad. Sci. 2002;99:4489–4494. [Europe PMC free article] [Abstract] [Google Scholar]
  • Rajalingam K., Wunder C., Brinkmann V., Churin Y., Hekman M., Sievers C., Rapp U.R., Rudel T. Prohibitin is required for Ras-induced Raf–MEK–ERK activation and epithelial cell migration. Nat. Cell Biol. 2005;7:837–843. [Abstract] [Google Scholar]
  • Rodriguez C.I., Buchholz F., Galloway J., Sequerra R., Kasper J., Ayala R., Stewart A.F., Dymecki S.M. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 2000;25:139–140. [Abstract] [Google Scholar]
  • Sanz M.A., Tsang W.Y., Willems E.M., Grivell L.A., Lemire B.D., Van der Spek H., Nijtmans L.G.J. The mitochondrial prohibitin complex is essential for embryonic viability and germline function in Caenorhabditis elegans. J. Biol. Chem. 2003;278:32091–32099. [Abstract] [Google Scholar]
  • Sasaki Y., Derudder E., Hobeika E., Pelanda R., Reth M., Rajewsky K., Schmidt-Supprian M. Canonical NF-κB activity, dispensable for B cell development, replaces BAFF–receptor signals and promotes B cell proliferation upon activation. Immunity. 2006;24:729–739. [Abstract] [Google Scholar]
  • Schwenk F., Baron U., Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 1995;23:5080–5081. [Europe PMC free article] [Abstract] [Google Scholar]
  • Sharma A., Quadri A. Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc. Natl. Acad. Sci. 2004;101:17492–17497. [Europe PMC free article] [Abstract] [Google Scholar]
  • Song Z., Chen H., Fiket M., Alexander C., Chan D.C. OPA1 processing control mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J. Cell Biol. 2007;178:749–755. [Europe PMC free article] [Abstract] [Google Scholar]
  • Steglich G., Neupert W., Langer T. Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria. Mol. Cell. Biol. 1999;19:3435–3442. [Europe PMC free article] [Abstract] [Google Scholar]
  • Sun M.G., Williams J., Munoz-Pinedo C., Perkins G.A., Brown J.M., Ellisman M.H., Green D.R., Frey T.G. Correlated three-dimensional light and electron microscopy reveals transformation of mitochondria during apoptosis. Nat. Cell Biol. 2007;9:1057–1065. [Abstract] [Google Scholar]
  • Tatsuta T., Model K., Langer T. Formation of membrane-bound ring complexes by prohibitins in mitochondria. Mol. Biol. Cell. 2005;16:248–259. [Europe PMC free article] [Abstract] [Google Scholar]
  • Tavernarakis N., Driscoll M., Kyrpides N.C. The SPFH domain: Implicated in regulating targeted protein turnover in stomatins and other membrane-associated proteins. Trends Biochem. Sci. 1999;24:425–427. [Abstract] [Google Scholar]
  • Terashima M., Kim K.-M., Adachi T., Nielsen P.J., Reth M., Köhler G., Lamers M.C. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J. 1994;13:3782–3792. [Europe PMC free article] [Abstract] [Google Scholar]
  • Wang S., Fusaro G., Padmanabhan J., Chellappan S.P. Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene. 2002;21:8388–8396. [Abstract] [Google Scholar]
  • Züchner S., Mersiyanova I.V., Muglia M., Bissar-Tadmouri N., Rochelle J., Dadali E.L., Zappia M., Nelis E., Patitucci A., Senderek J., et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 2004;36:449–451. [Abstract] [Google Scholar]
Articles from Genes & Development are provided here courtesy of Cold Spring Harbor Laboratory Press

Full text links 

Read article at publisher's site: https://doi.org/10.1101/gad.460708

Read article for free, from open access legal sources, via Unpaywall: http://genesdev.cshlp.org/content/22/4/476.full.pdfUnpaywall

Free to read at www.genesdev.org
http://www.genesdev.org/cgi/content/abstract/22/4/476

Free after 12 months at www.genesdev.org
http://www.genesdev.org/cgi/content/full/22/4/476

Free after 12 months at www.genesdev.org
http://www.genesdev.org/cgi/reprint/22/4/476

Citations & impact 

Impact metrics

340
Citations
Jump to Citations
8
Data citations
Jump to Data

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/102022204
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/102022204

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1101/gad.460708

Supporting
Mentioning
Contrasting
48
550
4

Article citations

Go to all (340) article citations

Data 

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.